Human Recombinant CRLF2 protein, ECD, hFc Tag-1 (V2LY-0526-LY3381)

Go to compare Compare Online Inquiry
Request for COA
Datasheet Target References Q & As Review & reward Protocols Associated Products

Basic Information

Expressed Host
HEK293 Cells
Protein Species
Human
Tag
hFc Tag
Protein Construction
This product is Human Recombinant CRLF2 protein, ECD, hFc Tag consist of Amino Acid: 1-231 and predicts a molecular mass of 50.91 kDa.
Molecule Mass
50.91 kDa
Protein Domain
ECD
Sequence
Amino Acid: 1-231
Species
Human

Formulations & Storage [For reference only, actual COA shall prevail!]

Purity
>95% as determined by SDS-PAGE.
Endotoxin
Please contact us for more information.
Format
Lyophilized
Reconstitution
Allow the vial and reconstitution buffer to equilibrate to room temperature. Briefly centrifuge or tap down the vial to ensure that all lyophilized powder is collected at the bottom of the vial. For the reconstitution of this product, we recommend adding PBS or sterile water to achieve a final antibody concentration of 1 mg/mL. Allow the vial to reconstitute for 10-15 minutes at room temperature with gentle agitation. Avoid vigorous shaking that can cause foaming and antibody denaturation. Aliquot into volumes based on your experiment and store liquid protein at -20°C or -80°C for long time.
Buffer
Lyophilized from sterile PBS
Preservative
None
Storage
Samples are stable for up to twelve months from date of receipt at -20°C to -80°C. Store it under sterile conditions at -20°C to -80°C. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
More Infomation

Target

Full Name
Cytokine Receptor Like Factor 2
Function
Receptor for thymic stromal lymphopoietin (TSLP). Forms a functional complex with TSLP and IL7R which is capable of stimulating cell proliferation through activation of STAT3 and STAT5. Also activates JAK2 (By similarity).

Implicated in the development of the hematopoietic system.
Biological Process
Cytokine-mediated signaling pathway Source: UniProtKB
Interleukin-7-mediated signaling pathway Source: Reactome
Oncostatin-M-mediated signaling pathway Source: GOC
Positive regulation of cell population proliferation Source: UniProtKB
Positive regulation of interleukin-5 production Source: UniProtKB
Positive regulation of mast cell activation Source: UniProtKB
Positive regulation of receptor signaling pathway via STAT Source: UniProtKB
Cellular Location
Isoform 1: Cell membrane
Isoform 2: Secreted
Topology
Extracellular: 23-231
Helical: 232-252
Cytoplasmic: 253-371

Rasekh, E. O., Atef, A. M., Khalil, M., Ebeid, E., Madney, Y., & Hamdy, N. (2021). Characterization of CRLF2 Expression in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia. Clinical Laboratory, 67(1).

Mohamed, S. M., Wohlmann, A., Schofield, P., Sia, K. C., McCalmont, H., Savvides, S. N., ... & Lock, R. B. (2021). A recombinant antibody fragment directed to the thymic stromal lymphopoietin receptor (CRLF2) efficiently targets pediatric Philadelphia chromosome-like acute lymphoblastic leukemia. International Journal of Biological Macromolecules, 190, 214-223.

Moreno-Lorenzana, D., Juárez-Velázquez, R., Martínez-Anaya, D., & Péez-Vera, P. (2020). CRLF2 (cytokine receptor like factor 2). Atlas of Genetics and Cytogenetics in Oncology and Haematology.

Meyer, L. K., Delgado-Martin, C., Maude, S. L., Shannon, K. M., Teachey, D. T., & Hermiston, M. L. (2019). CRLF2 rearrangement in Ph-like acute lymphoblastic leukemia predicts relative glucocorticoid resistance that is overcome with MEK or Akt inhibition. PloS one, 14(7), e0220026.

Zhang, Q., Shi, C., Han, L., Jain, N., Roberts, K. G., Ma, H., ... & Konopleva, M. (2018). Inhibition of mTORC1/C2 signaling improves anti-leukemia efficacy of JAK/STAT blockade in CRLF2 rearranged and/or JAK driven Philadelphia chromosome–like acute B-cell lymphoblastic leukemia. Oncotarget, 9(8), 8027.

Pastorczak, A., Sedek, L., Braun, M., Madzio, J., Sonsala, A., Twardoch, M., ... & Młynarski, W. (2018). Surface expression of Cytokine Receptor-Like Factor 2 increases risk of relapse in pediatric acute lymphoblastic leukemia patients harboring IKZF1 deletions. Oncotarget, 9(40), 25971.

Mangaonkar, A., Patnaik, M. M., Kaiser-Rogers, K., Rao, K. W., Halling, K., Oliver, G., ... & Van Dyke, D. L. (2017). Cytokine Receptor-like Factor 2 (CRLF2) Overexpression in Myeloid Malignancies Secondary to Multiple Isodicentric Y Chromosomes: A Novel Cytogenetic Entity?. Blood, 130, 1702.

Konoplev, S., Lu, X., Konopleva, M., Jain, N., Ouyang, J., Goswami, M., ... & Wang, S. A. (2017). CRLF2-Positive B-Cell Acute Lymphoblastic Leukemia in Adult PatientsA Single-Institution Experience. American journal of clinical pathology, 147(4), 357-363.

Ask a question We look forward to hearing from you.
0 reviews or Q&As
Loading...
Have you used Human Recombinant CRLF2 protein, ECD, hFc Tag-1?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon $30 eGift Card
Submit a review
Loading...
For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Contact us

  • Tel: (USA)
  • (UK)
  • Fax:
  • Email:

Submit A Review

online inquiry
Online Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.